AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32544361 — intervention group
Group type: EXPERIMENTAL
Intervention: bivalent HPV‐16/18 vaccine with a 2nd interval of 103–139 d
Number of subjects: 3689
Study 32544361 — intervention group
Group type: EXPERIMENTAL
Intervention: bivalent HPV‐16/18 vaccine with a 2nd interval of 140–160 d
Number of subjects: 3689
Study 32544361 — intervention group
Group type: EXPERIMENTAL
Intervention: bivalent HPV‐16/18 vaccine with a 2nd interval of 161–198 d
Number of subjects: 3689
Study 33466879 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aids used in TKR surgery
Number of subjects: 17
Study 33466879 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aids
Number of subjects: 17
Study 33466879 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative studies
Number of subjects: 17
Study 35262615 — intervention group
Group type: EXPERIMENTAL
Intervention: Volumes 2 and 3 recommendations
Number of subjects: 409
Study 35262615 — intervention group
Group type: COMPARATOR
Intervention: Volume 1 recommendations (control)
Number of subjects: 409
Study 32145041 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine-naloxone 100:1 (75 mg: 0.75 mg)
Number of subjects: 43
Study 32145041 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine-naloxone 200:1 (75 mg: 0.375 mg)
Number of subjects: 43
Study 32145041 — intervention group
Group type: COMPARATOR
Intervention: morphine mono (75 mg)
Number of subjects: 43
Study 34928306 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab 70 mg
Number of subjects: 2682
Study 34928306 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab 140 mg
Number of subjects: 2682
Study 34928306 — intervention group
Group type: COMPARATOR
Intervention: Erenumab (both doses)
Number of subjects: 2682
Study 34908832 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium/Olodaterol
Number of subjects: 69
Study 34908832 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium
Number of subjects: 69
Study 33279603 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric-coated fast release formulation
Number of subjects: 0
Study 33279603 — intervention group
Group type: EXPERIMENTAL
Intervention: TS1 system (time scale factor between Tvitro and Tvivo equals to 1)
Number of subjects: 0
Study 33279603 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIVC model
Number of subjects: 0
Study 32414548 — intervention group
Group type: EXPERIMENTAL
Intervention: 3dMDface scanning system (3dMD Inc, Atlanta, Ga)
Number of subjects: 279
Study 35912151 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c = 7% group
Number of subjects: 233
Study 35912151 — intervention group
Group type: COMPARATOR
Intervention: HbA1c > 7% group
Number of subjects: 233
Study 35912151 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c level
Number of subjects: 233
Study 35912151 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 233
Study 33058774 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous (IV) dexamethasone
Number of subjects: 130
Study 33058774 — intervention group
Group type: COMPARATOR
Intervention: Submucosal (SM) dexamethasone
Number of subjects: 130
Study 35380237 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive (RG, n = 15)
Number of subjects: 199
Study 35380237 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled Crying (CCG, n = 18)
Number of subjects: 199
Study 35380237 — intervention group
Group type: COMPARATOR
Intervention: Control (Treatment as Usual, TAUG, n = 8)
Number of subjects: 199
Study 33620762 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg
Number of subjects: 154
Study 33620762 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 154
Study 33620762 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study 32596755 — intervention group
Group type: EXPERIMENTAL
Intervention: Twisted wire splint (0.0175 stainless steel twisted wire)
Number of subjects: 260
Study 32596755 — intervention group
Group type: COMPARATOR
Intervention: Ribbon wire (single-strand ribbon titanium wire)
Number of subjects: 260
Study 36056407 — intervention group
Group type: COMPARATOR
Intervention: Service as usual (SAU) alone
Number of subjects: 284
Study 33834913 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Atkins diet
Number of subjects: 91
Study 33834913 — intervention group
Group type: COMPARATOR
Intervention: Control group (no diet)
Number of subjects: 91
Study 32212354 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral Nutrition (PN)
Number of subjects: 148
Study 32212354 — intervention group
Group type: COMPARATOR
Intervention: Oral Feeding (OF)
Number of subjects: 148
Study 35151260 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding in public (image of a woman breastfeeding)
Number of subjects: 506
Study 35151260 — intervention group
Group type: COMPARATOR
Intervention: Non-breastfeeding (image of a woman not breastfeeding)
Number of subjects: 506
Study 34077509 — intervention group
Group type: EXPERIMENTAL
Intervention: Risankizumab 180 mg every 8 weeks
Number of subjects: 65
Study 34077509 — intervention group
Group type: EXPERIMENTAL
Intervention: Risankizumab 600 mg every 4 weeks (for reinduction of four patients)
Number of subjects: 65
Study 32063347 — intervention group
Group type: EXPERIMENTAL
Intervention: Construct #4 (4-core suture type configuration)
Number of subjects: 60
Study 32063347 — intervention group
Group type: EXPERIMENTAL
Intervention: Construct #4 (4-core type repair)
Number of subjects: 60
Study 32063347 — intervention group
Group type: EXPERIMENTAL
Intervention: Constructs #2, #3, and #4 (with Krackow locking sutures)
Number of subjects: 60
Study 32063347 — intervention group
Group type: EXPERIMENTAL
Intervention: Construct #2
Number of subjects: 60
Study 32063347 — intervention group
Group type: EXPERIMENTAL
Intervention: Construct #3
Number of subjects: 60
Study 32063347 — intervention group
Group type: EXPERIMENTAL
Intervention: Construct #4
Number of subjects: 60
Study 34920425 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial disc replacement (ADR)
Number of subjects: 143
Study 34920425 — intervention group
Group type: COMPARATOR
Intervention: Fusion surgery
Number of subjects: 143
Study 34920425 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI assessment of adjacent-segment pathology (ASP)
Number of subjects: 143
Study 36287638 — intervention group
Group type: EXPERIMENTAL
Intervention: Time lapse system (TLS)
Number of subjects: 585
Study 36287638 — intervention group
Group type: COMPARATOR
Intervention: Standard benchtop incubator
Number of subjects: 585
Study 36287638 — intervention group
Group type: EXPERIMENTAL
Intervention: ICSI fertilized embryos
Number of subjects: 585
Study 36287638 — intervention group
Group type: COMPARATOR
Intervention: Conventional IVF fertilized embryos
Number of subjects: 585
Study 36287638 — intervention group
Group type: EXPERIMENTAL
Intervention: Time lapse system (TLS) and Standard benchtop incubator
Number of subjects: 585
Study 33670454 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-Awareness-Strengthening Lifestyle (HASL) program
Number of subjects: 92
Study 33670454 — intervention group
Group type: COMPARATOR
Intervention: Control group (passive request for HASL program after post-test)
Number of subjects: 92
Study 34125259 — intervention group
Group type: EXPERIMENTAL
Intervention: i-gel laryngeal mask airway
Number of subjects: 160
Study 34125259 — intervention group
Group type: COMPARATOR
Intervention: classic laryngeal mask airway (LMA)
Number of subjects: 160
Study 34125259 — intervention group
Group type: COMPARATOR
Intervention: laryngeal tube (LT)
Number of subjects: 160
Study 34781362 — intervention group
Group type: EXPERIMENTAL
Intervention: CloFluBu conditioning regimen
Number of subjects: 155
Study 32271354 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus docetaxel
Number of subjects: 78
Study 32271354 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 78
Study 35514364 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based NMES therapy
Number of subjects: 156
Study 35514364 — intervention group
Group type: COMPARATOR
Intervention: Sham low-voltage NMES group
Number of subjects: 156
Study 34956568 — intervention group
Group type: EXPERIMENTAL
Intervention: All-round care on the basis of conventional care
Number of subjects: 60
Study 34956568 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 60
Study 33034159 — intervention group
Group type: EXPERIMENTAL
Intervention: CASS with interested confederates
Number of subjects: 50
Study 33034159 — intervention group
Group type: COMPARATOR
Intervention: CASS with bored confederates
Number of subjects: 50
Study 33034159 — intervention group
Group type: EXPERIMENTAL
Intervention: CASS social behavior and social cognition tasks
Number of subjects: 50
Study 33034159 — intervention group
Group type: EXPERIMENTAL
Intervention: CASS social behavior
Number of subjects: 50
Study 33034159 — intervention group
Group type: EXPERIMENTAL
Intervention: CASS
Number of subjects: 50
Study 32439482 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day azithromycin (AZM) only (n=12)
Number of subjects: 24
Study 32439482 — intervention group
Group type: COMPARATOR
Intervention: Scaling and prescribed AZM after 2 months (n=12)
Number of subjects: 24
Study 35150170 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate loading (placement of permanent prosthesis within 7 days)
Number of subjects: 41
Study 35150170 — intervention group
Group type: COMPARATOR
Intervention: Delayed loading (placement of permanent prosthesis after 3 months)
Number of subjects: 41
Study 33909052 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed consent documents from COVID-19 vaccine trials
Number of subjects: 4
Study 33909052 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved informed consent document
Number of subjects: 4
Study 33938260 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year extension of early intervention
Number of subjects: 160
Study 33938260 — intervention group
Group type: COMPARATOR
Intervention: Step-down psychiatric care
Number of subjects: 160
Study 32591433 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1-MVA 5T4 vaccine
Number of subjects: 40
Study 33078646 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-vitamin-mineral supplement (MVMS)
Number of subjects: 54
Study 34401514 — intervention group
Group type: EXPERIMENTAL
Intervention: Epley maneuver
Number of subjects: 80
Study 34401514 — intervention group
Group type: COMPARATOR
Intervention: Semont maneuver
Number of subjects: 80
Study 32538835 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased serum calcium level (per 1 standard deviation (SD) increase 0.5 mg/dL)
Number of subjects: 54062
Study 34271963 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-agent oral selinexor
Number of subjects: 100
Study 32535481 — intervention group
Group type: EXPERIMENTAL
Intervention: Abelmoschus manihot (AM) 2.5 g three times per day for 48 weeks
Number of subjects: 1470
Study 32535481 — intervention group
Group type: COMPARATOR
Intervention: losartan potassium 100 mg per day for 48 weeks
Number of subjects: 1470
Study 32535481 — intervention group
Group type: EXPERIMENTAL
Intervention: Abelmoschus manihot (AM)
Number of subjects: 1470
Study 32535481 — intervention group
Group type: COMPARATOR
Intervention: losartan potassium
Number of subjects: 1470
Study 35460807 — intervention group
Group type: EXPERIMENTAL
Intervention: VR exergaming during cycling
Number of subjects: 34
Study 35460807 — intervention group
Group type: COMPARATOR
Intervention: Standard exercise (without VR)
Number of subjects: 34
Study 33931254 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to podcasts while driving
Number of subjects: 100
Study 33931254 — intervention group
Group type: COMPARATOR
Intervention: Sitting undistracted while listening to podcasts
Number of subjects: 100
Study 35919945 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib monotherapy
Number of subjects: 0
Study 35919945 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib plus csDMARD therapy
Number of subjects: 0
Study 35919945 — intervention group
Group type: COMPARATOR
Intervention: csDMARD-only therapy
Number of subjects: 0
Study 35919945 — intervention group
Group type: COMPARATOR
Intervention: bDMARD plus csDMARD therapy
Number of subjects: 0
Study 35919945 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib
Number of subjects: 0
Study 33257661 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-mg oral methotrexate once weekly with daily 5-mg folic acid for 12 weeks
Number of subjects: 92
Study 33257661 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo with daily 5-mg folic acid for 12 weeks
Number of subjects: 92
Study 37225870 — intervention group
Group type: COMPARATOR
Intervention: Conventional irrigation
Number of subjects: 80
Study 37225870 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonic irrigation activation system
Number of subjects: 80
Study 37225870 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation with a 980 nm diode laser and conventional irrigation
Number of subjects: 80
Study 37225870 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation with a 980 nm diode laser and sonic irrigation activation system
Number of subjects: 80
Study 33588596 — intervention group
Group type: EXPERIMENTAL
Intervention: Edaravone dexborneol
Number of subjects: 1165
Study 33588596 — intervention group
Group type: COMPARATOR
Intervention: Edaravone
Number of subjects: 1165
Study 35985457 — intervention group
Group type: COMPARATOR
Intervention: 74 Gy/37 fractions (Fr)
Number of subjects: 3216
Study 35985457 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 Gy/20 Fr
Number of subjects: 3216
Study 35985457 — intervention group
Group type: EXPERIMENTAL
Intervention: 57 Gy/19 Fr
Number of subjects: 3216
Study 32578778 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided thoracic paravertebral nerve block (TPVB)
Number of subjects: 100
Study 32578778 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided intercostal nerve block (ICNB)
Number of subjects: 100
Study 35114353 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient integrated palliative care
Number of subjects: 210
Study 35114353 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 210
Study 34107180 — intervention group
Group type: EXPERIMENTAL
Intervention: wMel-infected Aedes aegypti mosquito deployments (intervention clusters)
Number of subjects: 8144
Study 34107180 — intervention group
Group type: COMPARATOR
Intervention: No deployments (control clusters)
Number of subjects: 8144
Study 35248681 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored postal reminder intervention (showing information on the nearest clinic from each participant's address)
Number of subjects: 21017
Study 35248681 — intervention group
Group type: COMPARATOR
Intervention: Standard postal reminder (containing just the URL of the website listing all available clinics)
Number of subjects: 21017
Study 35248681 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored postal reminder intervention
Number of subjects: 21017
Study 32139496 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-delivered sleep restriction therapy (SRT) plus sleep hygiene booklet
Number of subjects: 588
Study 32139496 — intervention group
Group type: COMPARATOR
Intervention: Sleep hygiene booklet on its own
Number of subjects: 588
Study 33556413 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg/day (n = 32)
Number of subjects: 51
Study 33556413 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (n = 19)
Number of subjects: 51
Study 33556413 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg/day (n = 32) in statin non-users
Number of subjects: 51
Study 33084475 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Lifespan Integration (MLI) - one session of 90-140 minutes
Number of subjects: 38
Study 34195214 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone pulses plus tacrolimus and standard of care (SoC)
Number of subjects: 55
Study 34195214 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SoC) alone
Number of subjects: 55
Study 35184326 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aripiprazole adjunctive to antidepressant therapy
Number of subjects: 0
Study 35184326 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34024791 — intervention group
Group type: EXPERIMENTAL
Intervention: Active high frequency navigated perilesional rTMS
Number of subjects: 32
Study 34024791 — intervention group
Group type: COMPARATOR
Intervention: Sham high frequency navigated perilesional rTMS
Number of subjects: 32
Study 35429381 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.COV2.S vaccine
Number of subjects: 380
Study 34057625 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioabsorbable mesh plus continuous polydioxanone suture (PDS)
Number of subjects: 332
Study 34057625 — intervention group
Group type: COMPARATOR
Intervention: Continuous PDS single layer suture only
Number of subjects: 332
Study 33429750 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosentan combined with vardenafil oral group
Number of subjects: 0
Study 33429750 — intervention group
Group type: COMPARATOR
Intervention: Vardenafil oral group
Number of subjects: 0
Study 35611684 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone/bupropion sustained release for emotional hunger phenotype
Number of subjects: 0
Study 36272432 — intervention group
Group type: EXPERIMENTAL
Intervention: Molnupiravir (800 mg orally, twice daily for 5 days)
Number of subjects: 180
Study 36272432 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 36272432 — intervention group
Group type: EXPERIMENTAL
Intervention: Molnupiravir
Number of subjects: 180
Study 34399982 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sodium nitrate (700 mg×2)
Number of subjects: 82
Study 34399982 — intervention group
Group type: COMPARATOR
Intervention: Placebo (NaCl)
Number of subjects: 82
Study 32909657 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine Dependence (ND)
Number of subjects: 0
Study 32909657 — intervention group
Group type: COMPARATOR
Intervention: ADHD
Number of subjects: 0
Study 34183792 — intervention group
Group type: EXPERIMENTAL
Intervention: Teprotumumab
Number of subjects: 48
Study 34183792 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 33139276 — intervention group
Group type: EXPERIMENTAL
Intervention: Tribendimidine plus ivermectin
Number of subjects: 54
Study 33139276 — intervention group
Group type: COMPARATOR
Intervention: Tribendimidine monotherapy
Number of subjects: 54
Study 33139276 — intervention group
Group type: COMPARATOR
Intervention: Tribendimidine plus oxantel pamoate
Number of subjects: 54
Study 33326471 — intervention group
Group type: EXPERIMENTAL
Intervention: Paricalcitol
Number of subjects: 74
Study 33326471 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 74
Study 33966011 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (a-tDCS)
Number of subjects: 12
Study 33966011 — intervention group
Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 12
Study 33232172 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of methylphenidate (MPH)
Number of subjects: 12
Study 33232172 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose pill)
Number of subjects: 12
Study 33075067 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive MDA (quarterly single-dose praziquantel 40mg/kg; triple-dose albendazole 400mg)
Number of subjects: 13382
Study 33075067 — intervention group
Group type: COMPARATOR
Intervention: Standard Uganda government intervention (annual single-dose praziquantel 40mg/kg; 6-monthly single-dose albendazole)
Number of subjects: 13382
Study 35905412 — intervention group
Group type: EXPERIMENTAL
Intervention: Intragastric balloon (IGB) with diet/exercise counseling for 32 weeks
Number of subjects: 12
Study 35905412 — intervention group
Group type: COMPARATOR
Intervention: Counseling alone (control)
Number of subjects: 12
Study 34170206 — intervention group
Group type: EXPERIMENTAL
Intervention: Side camera perspective
Number of subjects: 93
Study 34170206 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot camera perspective
Number of subjects: 93
Study 34170206 — intervention group
Group type: EXPERIMENTAL
Intervention: Head camera perspective
Number of subjects: 93
Study 34170206 — intervention group
Group type: COMPARATOR
Intervention: All camera perspectives
Number of subjects: 93
Study 32233187 — intervention group
Group type: EXPERIMENTAL
Intervention: Gingival Unit Graft (GUG)
Number of subjects: 30
Study 32233187 — intervention group
Group type: COMPARATOR
Intervention: Free Gingival Graft (FGG)
Number of subjects: 30
Study 34086129 — intervention group
Group type: EXPERIMENTAL
Intervention: Inconsistent risk messages from public health experts and elected officials
Number of subjects: 3133
Study 34086129 — intervention group
Group type: EXPERIMENTAL
Intervention: Degree of infectiousness of the coronavirus
Number of subjects: 3133
Study 34086129 — intervention group
Group type: EXPERIMENTAL
Intervention: Distrust of vaccine safety and general vaccine avoidance
Number of subjects: 3133
Study 34086129 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity of COVID-19
Number of subjects: 3133
Study 34086129 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall intention to vaccinate
Number of subjects: 3133
Study 34343772 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D laparoscopic myomectomy
Number of subjects: 64
Study 34343772 — intervention group
Group type: COMPARATOR
Intervention: 2D laparoscopic myomectomy
Number of subjects: 64
Study 34086597 — intervention group
Group type: EXPERIMENTAL
Intervention: Linked Colour Imaging (LCI)
Number of subjects: 332
Study 34086597 — intervention group
Group type: COMPARATOR
Intervention: High-Definition White Light Endoscopy (HD-WLE)
Number of subjects: 332
Study 34703176 — intervention group
Group type: EXPERIMENTAL
Intervention: High scrotal approach
Number of subjects: 94
Study 34703176 — intervention group
Group type: COMPARATOR
Intervention: Conventional approach
Number of subjects: 94
Study 32433405 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic pancreaticoduodenectomy (RPD)
Number of subjects: 156
Study 32433405 — intervention group
Group type: COMPARATOR
Intervention: Open pancreaticoduodenectomy (OPD)
Number of subjects: 156
Study 36204954 — intervention group
Group type: EXPERIMENTAL
Intervention: nano-hydroxyapatite composite material
Number of subjects: 72
Study 36204954 — intervention group
Group type: COMPARATOR
Intervention: hydroxyapatite composite material
Number of subjects: 72